Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6
出版年份 2018 全文链接
标题
Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6
作者
关键词
-
出版物
PROSTATE
Volume 78, Issue 6, Pages 426-434
出版商
Wiley
发表日期
2018-01-31
DOI
10.1002/pros.23487
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals
- (2017) Hai Huang et al. PROSTATE
- Loss of α-Tubulin Acetylation Is Associated with TGF-β-induced Epithelial-Mesenchymal Transition
- (2016) Shuchen Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blocking the association of HDAC4 with MAP1S accelerates autophagy clearance of mutant Huntingtin
- (2015) Fei Yue et al. Aging-US
- Potassium Bisperoxo(1,10-phenanthroline)oxovanadate (bpV(phen)) Induces Apoptosis and Pyroptosis and Disrupts the P62-HDAC6 Protein Interaction to Suppress the Acetylated Microtubule-dependent Degradation of Autophagosomes
- (2015) Qi Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondria: diversity in the regulation of the NLRP3 inflammasome
- (2015) Prajwal Gurung et al. TRENDS IN MOLECULAR MEDICINE
- Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer
- (2014) Xianhan Jiang et al. CANCER
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients
- (2014) Xianhan Jiang et al. MOLECULAR CARCINOGENESIS
- Inflammasome: Cancer's friend or foe?
- (2014) Michela Terlizzi et al. PHARMACOLOGY & THERAPEUTICS
- Autophagy Inhibitor LRPPRC Suppresses Mitophagy through Interaction with Mitophagy Initiator Parkin
- (2014) Jing Zou et al. PLoS One
- Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy
- (2014) J. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability
- (2013) Jing Zou et al. BIOCHEMICAL JOURNAL
- SQSTM1/p62 Interacts with HDAC6 and Regulates Deacetylase Activity
- (2013) Jin Yan et al. PLoS One
- Inflammasomes and Their Roles in Health and Disease
- (2012) Mohamed Lamkanfi et al. Annual Review of Cell and Developmental Biology
- MAP1S enhances autophagy to suppress tumorigenesis
- (2012) Leyuan Liu et al. Autophagy
- Hypertrophy and Unconventional Cell Division of Hepatocytes Underlie Liver Regeneration
- (2012) Yuichiro Miyaoka et al. CURRENT BIOLOGY
- Emerging avenues linking inflammation and cancer
- (2012) Joydeb Kumar Kundu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Fibrosis-dependent mechanisms of hepatocarcinogenesis
- (2012) David Y. Zhang et al. HEPATOLOGY
- Inflammasomes in health and disease
- (2012) Till Strowig et al. NATURE
- Autophagy Enhanced by Microtubule- and Mitochondrion-Associated MAP1S Suppresses Genome Instability and Hepatocarcinogenesis
- (2011) R. Xie et al. CANCER RESEARCH
- Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
- (2011) Jones T. Nauseef et al. Nature Reviews Urology
- Acetylated microtubules are required for fusion of autophagosomes with lysosomes
- (2010) Rui Xie et al. BMC CELL BIOLOGY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started